Woodbridge, NJNCT07446582Now EnrollingIRB Ready

Age-Related (Dry) Macular Degeneration Clinical Trial in Woodbridge, NJ

Access cutting-edge age-related (dry) macular degeneration treatment through this clinical trial at a research site in Woodbridge. Study-provided care at no cost to qualified participants.

Sponsored by AI-Spectral

Quick Self-Assessment

See if you qualify for this Woodbridge location

Preparing your pre-screening questions…

Expert Care in Woodbridge

Access age-related (dry) macular degeneration specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related age-related (dry) macular degeneration treatment provided free

Apply for This Woodbridge Location

Check if you qualify for this age-related (dry) macular degeneration clinical trial in Woodbridge, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Woodbridge

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Woodbridge site if eligible
  4. 4Begin participation

About This Age-Related (Dry) Macular Degeneration Study in Woodbridge

The goal of this observational clinical study is to learn if DeepMSI AI detects age-related macular degeneration (AMD) biomarkers with sensitivity and specificity equivalent to experienced clinicians in adults over 40 years old. The main questions it aims to answer are: * Does DeepMSI AI detect AMD biomarkers with sensitivity equivalent to experienced clinicians? * Does DeepMSI AI detect AMD biomarkers with specificity equivalent to experienced clinicians? Participants' eyes will be imaged by MSI-120 and their images will be analyzed for AMD biomarkers by both DeepMSI AI and retina specialists independently. Researchers will compare retina image analysis from DeepMSI AI with ground truth (clinicians' interpretations) to see if AI achieves equivalency in sensitivity and specificity.

Sponsor: AI-Spectral

Who Can Participate

Inclusion Criteria

AMD subjects:
Subjects over 40 years of age diagnosed for ne AMD
Subject must be able to understand and must sign an IRB-approved ICF
Subject must have minimum of one prior visit to the clinic
Prior imaging must show signs of neAMD (e.g. drusen of different sizes and types with macular pigmentary changes, complete or incomplete retinal pigment epithelium and outer retinal atrophy) at least in one eye Healthy subjects:
Subjects over 40 years of age have not been diagnosed with any type of AMD and prior imaging that shows no signs of AMD or other types of retinopathies.
A minimum of light perception visual acuity is required to detect the fixation target during imaging.
Two masked clinicians must confirm and categorize them into healthy eyes. -

Exclusion Criteria

Assessed prior to any considerations of inclusion:
Eyes with significant refractive media opacity (e.g. corneal opacity, significant cataract) that prevents adequate imaging
Severe Refractive Error: Extreme high myopia (≥ -10.00D) or hyperopia (≥ +6.00D) that may compromise image quality.
Unstable Ocular Conditions: Active ocular infections, severe uveitis, or status-post ocular trauma
Recent Intraocular Surgery: Patients who have undergone intraocular surgery (e.g., cataract, retinal, or glaucoma surgery) within the past 3 months (except for intravitreal injections for GA therapy).
History or Current Evidence of other types of retinopathy other than neAMD, e.g. Acute Retinal artery or Vein Occlusion, Diabetic Retinopathy, Idiopathic Epiretinal membrane, Myopic Maculopathy, Hypertension Retinopathy etc.
History of Vitrectomy or Scleral Buckling for any kind of Vitreoretinopathy, e.g. Retinal Detachment, Epiretinal Membrane, Proliferative Diabetic Retinopathy etc. that could distort imaging results.
Inability to Maintain Fixation: Including patients with advanced nystagmus, severe amblyopia, or cognitive impairments (dementia) affecting fixation stability.
Severe Dry Eye or Ocular Surface Disease: Conditions that may interfere with imaging quality or patient comfort during the procedure.
Subjects with essential tremor (head and neck tremors or unstable fixation to prevent adequate imaging)
Inability to understand and refusal to sign informed consent

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Woodbridge?

Yes, this clinical trial (NCT07446582) has an active research site in Woodbridge, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Age-Related (Dry) Macular Degeneration Treatment Options in Woodbridge, NJ

If you're searching for age-related (dry) macular degeneration treatment options in Woodbridge, NJ, this clinical trial (NCT07446582) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Woodbridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced age-related (dry) macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all age-related (dry) macular degeneration clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Woodbridge, NJ

See all rheumatoid arthritis clinical trials recruiting in Woodbridge — not just this study.

Browse Rheumatoid Arthritis Trials in Woodbridge →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsErectile Dysfunction TrialsMacular Degeneration TrialsAll Conditions →

Ready to Join in Woodbridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Woodbridge, NJ